DK1282616T3 - Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter - Google Patents

Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter

Info

Publication number
DK1282616T3
DK1282616T3 DK01918113T DK01918113T DK1282616T3 DK 1282616 T3 DK1282616 T3 DK 1282616T3 DK 01918113 T DK01918113 T DK 01918113T DK 01918113 T DK01918113 T DK 01918113T DK 1282616 T3 DK1282616 T3 DK 1282616T3
Authority
DK
Denmark
Prior art keywords
hydroxyphenylpiperidin
ylidene
pain
treatment
methylbenzamide
Prior art date
Application number
DK01918113T
Other languages
Danish (da)
English (en)
Inventor
Zhongyong Wei
William Brown
Christopher Walpole
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1282616T3 publication Critical patent/DK1282616T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DK01918113T 2000-04-04 2001-03-30 Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter DK1282616T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001207A SE0001207D0 (sv) 2000-04-04 2000-04-04 Novel compounds

Publications (1)

Publication Number Publication Date
DK1282616T3 true DK1282616T3 (da) 2004-09-20

Family

ID=20279146

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01918113T DK1282616T3 (da) 2000-04-04 2001-03-30 Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter

Country Status (29)

Country Link
US (1) US6756387B2 (de)
EP (1) EP1282616B1 (de)
JP (1) JP2003529596A (de)
KR (1) KR20020084285A (de)
CN (1) CN1185228C (de)
AR (1) AR027983A1 (de)
AT (1) ATE269324T1 (de)
AU (1) AU2001244981A1 (de)
BR (1) BR0109816A (de)
CA (1) CA2404386A1 (de)
CZ (1) CZ20023289A3 (de)
DE (1) DE60103889T2 (de)
DK (1) DK1282616T3 (de)
EE (1) EE200200571A (de)
ES (1) ES2220748T3 (de)
HK (1) HK1051690A1 (de)
HU (1) HUP0300427A2 (de)
IL (1) IL151890A0 (de)
IS (1) IS6575A (de)
MX (1) MXPA02009757A (de)
NO (1) NO20024775L (de)
NZ (1) NZ522142A (de)
PL (1) PL357780A1 (de)
PT (1) PT1282616E (de)
RU (1) RU2002125495A (de)
SE (1) SE0001207D0 (de)
SK (1) SK14232002A3 (de)
WO (1) WO2001074804A1 (de)
ZA (1) ZA200207968B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE0101768D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101765D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101770D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101767D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101766D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0103313D0 (sv) * 2001-10-03 2001-10-03 Astrazeneca Ab Novel compounds
AU2003214800A1 (en) 2002-01-02 2003-07-24 Ardent Pharmaceuticals, Inc. Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203301D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0300104D0 (sv) * 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300105D0 (sv) * 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) * 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300987D0 (sv) * 2003-04-03 2003-04-03 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301443D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301445D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301442D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
SE0301441D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
MXPA05012117A (es) * 2003-05-16 2006-02-08 Astrazeneca Ab Derivados de diarilmetiliden piperidina, preparaciones de los mismos y usos de los mismos.
EP1644373A1 (de) * 2003-06-27 2006-04-12 Janssen Pharmaceutica N.V. Tricyclische delta-opioid-modulatoren
SE0400026D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0402485D0 (sv) 2004-10-13 2004-10-13 Astrazeneca Ab Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride salt

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2898339A (en) 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US4581171A (en) 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4816586A (en) 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5140029A (en) 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
US4939137A (en) 1989-06-28 1990-07-03 Ortho Pharmaceutical Corporation Ring-fused thienopyrimidinedione derivatives
US5683998A (en) 1991-04-23 1997-11-04 Toray Industries, Inc. Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
JP4754068B2 (ja) * 1997-12-24 2011-08-24 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類

Also Published As

Publication number Publication date
PL357780A1 (en) 2004-07-26
RU2002125495A (ru) 2004-04-10
SE0001207D0 (sv) 2000-04-04
US6756387B2 (en) 2004-06-29
NO20024775D0 (no) 2002-10-03
EE200200571A (et) 2004-04-15
CN1432009A (zh) 2003-07-23
ES2220748T3 (es) 2004-12-16
AR027983A1 (es) 2003-04-23
AU2001244981A1 (en) 2001-10-15
HK1051690A1 (en) 2003-08-15
KR20020084285A (ko) 2002-11-04
BR0109816A (pt) 2003-01-21
WO2001074804A1 (en) 2001-10-11
SK14232002A3 (sk) 2003-06-03
NO20024775L (no) 2002-12-03
NZ522142A (en) 2004-06-25
ATE269324T1 (de) 2004-07-15
JP2003529596A (ja) 2003-10-07
EP1282616B1 (de) 2004-06-16
CZ20023289A3 (cs) 2003-03-12
ZA200207968B (en) 2004-04-07
HUP0300427A2 (hu) 2003-06-28
EP1282616A1 (de) 2003-02-12
MXPA02009757A (es) 2003-05-27
DE60103889D1 (de) 2004-07-22
IS6575A (is) 2002-09-30
PT1282616E (pt) 2004-10-29
US20030187022A1 (en) 2003-10-02
CA2404386A1 (en) 2001-10-11
IL151890A0 (en) 2003-04-10
DE60103889T2 (de) 2005-08-25
CN1185228C (zh) 2005-01-19

Similar Documents

Publication Publication Date Title
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DK1292594T3 (da) Quinazolinderivater til behandling af tumorer
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK2412368T3 (da) Sammensætning til behandling af ar
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DE60136477D1 (de) Retinoide zur behandlung von emphysem
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
DK1434588T3 (da) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)aminoalkylsyrederivater til behandling af smerte
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser
DK1286986T3 (da) Quinolinylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerte
DK1158950T3 (da) antikonvulsive derivater til behandling af essentiel tremor
DK1282414T3 (da) Felbamatafledte forbindelser til behandling af neuropatisk smerte